Mark N. Lampert, 10% Owner at Capstone Therapeutics Corp. (CAPS), bought 358,600 shares at $0.25 ($90K) on 2011-07-18, disclosed to the SEC on 2011-07-18.
Open-market purchase of $90k CAPS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 19,700 | $5K | 5.5% |
| 2 | $0.25 | 28,900 | $7K | 8.1% |
| 3 | $0.25 | 310,000 | $78K | 86.4% |
| Total | $0.25 avg | 358,600 | $90K | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |